Citigroup’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-47,005
Closed -$1.11M 4991
2023
Q4
$1.11M Buy
47,005
+28,591
+155% +$675K ﹤0.01% 2078
2023
Q3
$275K Sell
18,414
-30,183
-62% -$450K ﹤0.01% 2796
2023
Q2
$532K Sell
48,597
-185,699
-79% -$2.03M ﹤0.01% 2697
2023
Q1
$2.04M Buy
234,296
+4,709
+2% +$41.1K ﹤0.01% 1525
2022
Q4
$1.44M Buy
229,587
+118,504
+107% +$743K ﹤0.01% 1742
2022
Q3
$389K Sell
111,083
-151,321
-58% -$530K ﹤0.01% 2751
2022
Q2
$774K Buy
262,404
+256,894
+4,662% +$758K ﹤0.01% 2274
2022
Q1
$17K Sell
5,510
-15,220
-73% -$47K ﹤0.01% 4507
2021
Q4
$70K Buy
20,730
+8,706
+72% +$29.4K ﹤0.01% 4157
2021
Q3
$44K Buy
12,024
+4,225
+54% +$15.5K ﹤0.01% 4061
2021
Q2
$34K Buy
7,799
+234
+3% +$1.02K ﹤0.01% 4341
2021
Q1
$34K Sell
7,565
-42,983
-85% -$193K ﹤0.01% 4273
2020
Q4
$291K Buy
50,548
+34,224
+210% +$197K ﹤0.01% 3001
2020
Q3
$119K Sell
16,324
-876,140
-98% -$6.39M ﹤0.01% 3043
2020
Q2
$3.12M Sell
892,464
-10,891
-1% -$38K ﹤0.01% 1329
2020
Q1
$1.34M Sell
903,355
-443,935
-33% -$657K ﹤0.01% 1617
2019
Q4
$2.64M Buy
1,347,290
+355,463
+36% +$697K ﹤0.01% 1502
2019
Q3
$5.08M Buy
991,827
+409,692
+70% +$2.1M ﹤0.01% 1065
2019
Q2
$4.17M Buy
582,135
+562,167
+2,815% +$4.03M ﹤0.01% 1194
2019
Q1
$265K Buy
19,968
+2
+0% +$27 ﹤0.01% 2942
2018
Q4
$157K Buy
19,966
+3,000
+18% +$23.6K ﹤0.01% 3240
2018
Q3
$188K Buy
16,966
+6,751
+66% +$74.8K ﹤0.01% 3204
2018
Q2
$137K Buy
10,215
+9,297
+1,013% +$125K ﹤0.01% 3202
2018
Q1
$12K Buy
+918
New +$12K ﹤0.01% 4427
2016
Q2
Sell
-324
Closed 5350
2016
Q1
$0 Buy
+324
New ﹤0.01% 5666
2015
Q1
Sell
-482
Closed -$5K 5708
2014
Q4
$5K Buy
482
+439
+1,021% +$4.55K ﹤0.01% 5050
2014
Q3
$0 Buy
+43
New ﹤0.01% 5639